MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Genetic markers revealed in dysregulated pathways in ischemic stroke may lead to Parkinson’s disease

    H. Singh, V. Swarup, A. Srivastava (Marseille, France)

    Objective: To assess differential expression and gene set enrichment analysis to identify biological pathways associated with stroke and Parkinson’s disease (PD). Further, putative drug targets…
  • 2019 International Congress

    Novel p.Pro193Arg missense mutation in ABCD1-gene associated with phenotype of ALD/AMN: a case report

    K. Steidel, J. Waldthaler, C. Eggers, D. Pedrosa (Marburg, Germany)

    Objective: To describe a novel mutation p.Pro193Arg of the ABCD1-Gene in a patient presenting with clinical phenotype of Adrenomyeloneuropathy (AMN). Background: Adrenoleukodystrophy comprises progressive neurologic…
  • 2019 International Congress

    Neurofascin is a novel gene associated with autosomal recessive spastic and polyneuropathy

    L. Straniero, E. Monfrini, S. Bonato, G. Monzio Compagnoni, A. Bordoni, R. Dilena, R. Silipigni, D. Ronchi, S. Duga, A. Di Fonzo (Pieve Emanuele, Milan, Italy)

    Objective: We aim to find the genetic defect causing infantile-onset ataxia and mild demyelinating neuropathy in two siblings of an Italian consanguineous family. Background: Neurofascin…
  • 2019 International Congress

    Genetic polymorphism (rs6971) in translocator protein (TSPO) and its clinical relevance in Parkinson’s disease

    P. Surathi, M. Matarazzo, A. Sethi, J. Mckenzie, N. Neilson, R. Ross, M. Schulzer, M. Farrer, S. Booromand, J. Stoessl (Vancouver, BC, Canada)

    Objective: The objective of this study will be to identify specific clinical patterns in Parkinson’s disease patients with respect to TSPO genetic polymorphism (rs69711). Background:…
  • 2019 International Congress

    Assessing the response to Levodopa/carbidopa intestinal gel infusion based on genetic status

    A. Thaler, V. Livneh, A. Hillel, H. Strauss, G. Yahalom, H. Shabtai, A. Migirov Senderovich, S. Israeli-Korn, T. Fay-Carmon, N. Giladi, S. Hassin Baer, T. Gurevich (Ramat Gan, Israel)

    Objective: The aim of this study was to characterize patients with Parkinson's disease (PD) on Levodopa/carbidopa intestinal gel infusion (LCIG) treatment based on their genetic…
  • 2019 International Congress

    Heterozygous DCC mutations, more than congenital mirror movements

    S. Thams, M. Islam, M. Lindefeldt, A. Nordgren, T. Granberg, D. Nilsson, M. Paucar (Stockholm, Sweden)

    Objective: To perform a comprehensive characterization of 5 patients with variable degree of congenital mirror movements. Background: Congenital mirror movements (CMM) are rare non-progressive syndromes…
  • 2019 International Congress

    Clinicopathologic Characterization and Abnormal Autophagy of HDLS

    W. Tian, L. Cao, S. Chen (Shanghai, China)

    Objective: We aimed to investigate clinical and pathological characteristics in hereditary diffuse leukoencephalopathy with spheroids (HDLS) patients and explore the potential impact of colony-stimulating factor…
  • 2019 International Congress

    Serum MIR-96-5P and MIR-339-5P as a Potential Biomarker for Multiple System Atrophy and Parkinson’s Disease

    A. Vallelunga, T. Iannitti, S. Capece, G. Somma, G. Dati, P. Barone, W. Meissner, M. Pellecchia (Salerno, Italy)

    Objective: The aim of our study was to to determine if serum mir-96-5p and mir-339-5p can be used as biomarkers for early diagnosis of Parkinson’s…
  • 2019 International Congress

    Screening of mutations in PARK2 gene and Dopamine levels in Parkinson’s disease (PD) patients in Coimbatore population, India

    B. Vellingiri, D. Venkatesan (Coimbatore, India)

    Objective: The aim of the present study was to perform the mutational screening of PARK2 gene and dopamine level in PD patients of Coimbatore population,…
  • 2019 International Congress

    Identification of genetic alterations and SNCA mutation in Parkinson’s disease patients of Coimbatore Population, India

    D. Venkatesan, B. Vellingiri (Coimbatore, India)

    Objective: The aim of the study is to analyze the genetic alterations in SNCA gene and dopamine transporter in 22 PD patients of Coimbatore population.…
  • « Previous Page
  • 1
  • …
  • 1240
  • 1241
  • 1242
  • 1243
  • 1244
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley